# Adlai Nortye (ANL) — News

ANL · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/anl/news

## Recent headlines

- [Adlai Nortye in clinical pact with Lilly & Merck KGaA](https://www.ainvest.com/news/adlai-nortye-clinical-pact-lilly-merck-kgaa-2610) — AInvest Wire, Oct 15, 2026
- [Adlai Nortye Group - Lilly to supply cetuximab for U.S. trials; Merck KGAA for Australia and China](https://www.ainvest.com/news/adlai-nortye-group-lilly-supply-cetuximab-trials-merck-kgaa-australia-china-2610) — AInvest Wire, Oct 15, 2026
- [ADLAI Nortye Group - Agreements support phase I trial of an4035 as monotherapy and with cetuximab](https://www.ainvest.com/news/adlai-nortye-group-agreements-support-phase-trial-an4035-monotherapy-cetuximab-2610) — AInvest Wire, Oct 15, 2026
- [ADLAI Nortye enters into clinical collaboration with Lilly and Merck KGaA, Darmstadt, Germany to evaluate combination of an4035 and cetuximab](https://www.ainvest.com/news/adlai-nortye-enters-clinical-collaboration-lilly-merck-kgaa-darmstadt-germany-evaluate-combination-an4035-cetuximab-2610) — AInvest Wire, Oct 15, 2026
- [L&T to report Q2 results on Oct. 27](https://www.ainvest.com/news/report-q2-results-oct-27-2610) — AInvest Wire, Oct 13, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).